ARCHIVES

CCOPS Unhappy With NCI Policy Limiting Their Participation In Early Phase 2 Clinical Trials

This article is from The Cancer Letter archive.

Vol. 09 No. 43 | November 11, 1983

Download PDF Visit The Full Archive

Related Articles

Three cancer societies to be led by Vanderbilt faculty in 2004

July 18, 2003

NCI’s New Divisional Structure In Place, Next Step Is Review Of Labs, Branches

October 13, 1995

NCCS Networker Volume 9 Issue 3, Summer 1995

June 12, 1995

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Bush Appoints Kripke To President’s Cancer Panel

March 21, 2003

NCI, IARC Sponsors Workshop On EBV

February 14, 1975